Cataract
Gene: MAN2B1
Classified as Definitive by Lysosomal Diseases GCEP on 02/09/2022 - https://search.clinicalgenome.org/CCID:005323Created: 12 May 2025, 2:38 p.m. | Last Modified: 12 May 2025, 2:38 p.m.
Panel Version: 1.2588
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
alpha-mannosidosis MONDO:0009561
Publications
Well established gene-disease association. Clinical features include intellectual disability, coarse facial features, skeletal abnormalities, hearing impairment, neurologic motor problems, and immune deficiency. Expression of the disease varies considerably, and there is a wide spectrum of clinical findings and severity. Affected children are often normal at birth and during early development. They present in early childhood with delayed motor development, delayed speech, and hearing loss. Additional features include large head with prominent forehead, rounded eyebrows, flattened nasal bridge, macroglossia, widely spaced teeth, dysostosis multiplex, and motor impairment.
Lenticular spoke-like opacities are part of the phenotype.Created: 13 Apr 2021, 6:48 p.m. | Last Modified: 24 Dec 2025, 1:16 p.m.
Panel Version: 0.450
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mannosidosis, alpha-, types I and II, MIM# 248500; MONDO:0009561
Gene: man2b1 has been classified as Green List (High Evidence).
Phenotypes for gene: MAN2B1 were changed from to Mannosidosis, alpha-, types I and II, MIM# 248500; MONDO:0009561
Publications for gene: MAN2B1 were set to
Mode of inheritance for gene: MAN2B1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: MAN2B1 was added gene: MAN2B1 was added to Cataract_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: MAN2B1 was set to Unknown